Normocin™ - Antimicrobial Reagent
Prevention Against Mycoplasma, Bacteria and Fungi
Normocin™ is used as a "routine addition" to cell culture media to prevent mycoplasma, bacterial and fungal contaminations in small or large scale animal cell cultures. Normocin™ can be used in combination with Pen-Strep solutions to broaden the anti-bacterial spectrum.
Normocin™ is an innovative formulation developed by InvivoGen of three antibiotics active against mycoplasmas, bacteria and fungi. Normocin™ contains two compounds that act on mycoplasmas and both Gram+ and Gram - bacteria by blocking DNA and protein synthesis. The third compound eradicates yeasts and fungi by disrupting ionic exchange through the cell membrane.
Product concentration: 50 mg/ml
Active concentration not toxic for treated cell lines: 100 μg/ml
1 ml Normocin™ is enough to treat 500 ml medium
Shipped at room temperature
Normocin™ is provided as a cell culture tested, sterile filtered red solution at a concentration of 50 mg/ml in different formats:
- 10 x 1 ml vial (500 mg)
- 1 x 20 ml bottle (1 g)
Recent articles using InvivoGen Normocin™ - Antimicrobial Reagent
- 2017 - Nat Commun., 8:14391.
IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP.
Jønsson KL. et al.
- 2017 - J Proteomics., S1874-3919(17)30009.
Comparative Proteomics of Paired Vocal Fold and Oral Mucosa Fibroblasts.
Karbiener M. et al.
- 2016 - Cancer Res., [Epub ahead of print]
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
Chang AL. et al.
- 2016 - Nat Struct Mol Biol., 23(4):286-92.
Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
Shukla S. et al.
- 2016 - Sci Rep., 6:36012
Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy.
Madge PD. et al.
|Unit Size||500 mg (10 x 1 ml)|
|Price||For price or distributor address,
please select your country